Dr. Jörg Ogorka is the founder and Managing Director of Ogorka Pharma Consulting GmbH since October 2021. He consults in pharmaceutical development, notably for Novartis in Life Cycle Management and academic institutions in 3D-printing. Previously, he held leadership roles at Novartis, focusing on CMC innovation and global project management. Ogorka also led Early Stage Development at Sandoz from 2018 to 2020. His expertise includes drug delivery technologies, value-added generics, and novel oral products. He holds a PhD in Pharmaceutical Chemistry and is a trained pharmacist.